Insider Trading Activity AnaptysBio, Inc. (NASDAQ:ANAB) – Major Shareholder Sold 37,040 shares of Stock

Insider Trading Activity For AnaptysBio, Inc. (NASDAQ:ANAB)

Ventures Vii L P Avalon , Major Shareholder of AnaptysBio, Inc. (NASDAQ:ANAB) reportedly Sold 37,040 shares of the company’s stock at an average price of 24.35 for a total transaction amount of $901,924.00 SEC Form

Insider Trading History For AnaptysBio, Inc. (NASDAQ:ANAB)

On 1/31/2017 Nicholas Lydon, Director, bought 16,666 with an average share price of $15.00 per share and the total transaction amounting to $249,990.00.View SEC Filing

On 1/31/2017 Healthcare Vii L.P. Frazier, Major Shareholder, bought 400,000 with an average share price of $15.00 per share and the total transaction amounting to $6,000,000.00.View SEC Filing

On 7/26/2017 Ventures Vii L P Avalon, Major Shareholder, sold 37,040 with an average share price of $24.35 per share and the total transaction amounting to $901,924.00.View SEC Filing

Analyst Ratings For AnaptysBio, Inc. (NASDAQ:ANAB)
These are 5 Buy Ratings .
The current consensus rating for AnaptysBio, Inc. (NASDAQ:ANAB) is Buy (Score: 3.00) with a consensus target price of $35.60 , a potential (45.31% upside)

Analyst Ratings History For AnaptysBio, Inc. (NASDAQ:ANAB)

• On 3/29/2017 Wedbush Lower Price Target of rating Outperform with a price target of $33.00 to $28.00
• On 3/31/2017 JMP Securities Reiterated Rating Outperform with a price target of $45.00
• On 4/18/2017 Credit Suisse Group Reiterated Rating Outperform with a price target of $34.00
• On 5/2/2017 Stifel Nicolaus Boost Price Target of rating Buy with a price target of $30.00 to $35.00
• On 7/10/2017 Robert W. Baird Initiated Coverage of rating Outperform to Outperform with a price target of $36.00

Recent Trading Activity for AnaptysBio, Inc. (NASDAQ:ANAB)
Shares of AnaptysBio, Inc. closed the previous trading session at 24.50 down -1.03 -4.03% with 394,429 shares trading hands.